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Water Usage 24-h composite sampling 
   (m3/d) (L/capita/d) Summer Winter 
A AS 92 23,000 250 22/23 & 27/28 Aug. 2013  
B TF 5.9 1,368 232 26/27 & 27/28 Jun. 2012 
23/24 & 27/28 Aug. 2013 
28/29 Aug. & 2/3 Sep. 2014 
18/19 & 21/22 Aug. 2015 
21/22 & 22/23 Jan. 
2015 
C TF 11.3 2,406 213 26/27 & 27/28 Jun. 2012 
26/27 & 27/28 Aug. 2013 
28/29 Aug. & 1/2 Sep. 2014 
18/19 & 21/22 Aug. 2015 
21/22 & 22/23 Jan. 
2015 
D AS 31.7 8,000 252 21/22 & 27/28 Aug. 2013 
1/2 & 2/3 Sep. 2014 
18/19 & 24/25 Aug. 2015 
20/21 Jan. 2015 
O AS 162.8 38,000 233 25/26 & 27/28 Jun. 2012 
21/22 & 26/27 Aug. 2013 
27/28 Aug. & 2/3 Sep. 2014 
18/19 & 20/21 Aug. 2015 
20/21 & 22/23 Jan. 
2015 
# AS: activated sludge treatment, TF: trickling filter treatment 





PPCPs freq. Max. Ave. freq. Max. Ave. freq. Max. Ave.
(%) (ng/L) (ng/L) (%) (ng/L) (ng/L) (%) (ng/L) (ng/L)
Acetaminophen 60 297,000 158,000 30 3,430 659 65 9,700 534
Antipyrine 0 9 5.7 3.4 9 2.4 1.0
Atenolol 100 2,940 1,720 95 564 344 88 457 60.0
Azithromycin 54 507 234 93 264 101 17 235 65.7
Bezafibrate 100 960 458 100 315 105 94 365 26.4
Caffeine 89 83,700 40,200 63 3,740 826 98 6,310 345
Carbamazepine 74 1,159 566 96 1,170 599 97 826 139
Chlortetracycline 0 0 0
Clarithromycin 66 773 414 98 377 94 61 230 28.0
Clenbuterol 3 2.9 2.9 0 0.4 0.1 0.1
Clofibric acid 3 0.8 0.8 2 0.3 0.3 13 4.6 0.7
Crotamiton 97 550 202 100 455 166 91 258 48.0
Cyclophosphamide 29 40.9 9.2 54 10 3.0 53 8.4 1.2
DEET 94 4,210 1390 100 6,190 401 71 590 94.7
Diclofec 71 504 257 89 406 177 84 330 37.5
Diltiazem 80 206 105 91 107 43.7 77 83.6 9.0
Dipyridamole 80 1,430 661 89 285 95 28 113 28.3
Disopyramide 43 84.4 43.1 74 102 38.2 70 111 13.6
Ethenzamide 14 32.7 19.1 5 6.8 4.7 6 6.0 0.8
Fenoprofen 0 0 0.4 3.1 3.1
Furosemide 57 3074 1242 81 1050 530 35 566 132
Griseofulvin 6 10.7 9.0 44 12 7.1 27 14.4 3.6
Ifenprodil 0 0 0
Indometacin 57 23.8 11.9 81 59 13 28 12.1 4.1
Isopropylantipyrine 9 1.3 0.9 16 22 3.8 12 1.8 0.3
Ketoprofen 74 135 54.0 65 71 11.7 15 25.3 6.1
Levofloxacin 34 119 44.4 67 47 6.9 10 8.0 2.9
Lincomycin 23 4.4 1.6 51 5.5 0.9 75 10.6 0.7
Mefemic acid 100 396 82.6 96 91 54 70 86.0 15.4
Metoprolol 97 68.1 31.3 100 37 24 53 38.3 8.9
Nalidixic acid 0 7 6.7 4.4 1 5.3 4.5
Naproxen 86 14,000 5890 91 1,760 495 89 683 49.1
Oxytetracycline 17 1,600 903 53 602 83 44 127 10.2
Pirenzepine 43 5.7 1.1 47 6.1 2.5 26 5.1 1.4
Primidone 71 226 102 88 235 84 85 85.0 17.9
Propranolol 83 326 136 89 291 90 84 130 15.7
Roxithromycin 20 9.1 3.9 65 9.1 4.7 36 7.7 1.8
Salbutamol 71 41.0 23.2 68 32 19 28 21.2 7.5
Sulfadimethoxine 3 2.6 2.6 9 4.6 3.7 4 2.0 0.8
Sulfamerazine 31 29.6 17.2 33 60 15 29 30.0 2.4
Sulfamethoxazole 94 356 142 95 227 76 88 146 23.1
Sulfamonomethoxine 11 2.5 1.2 9 1.2 0.4 17 0.7 0.2
Sulfapyridine 71 1,240 782 84 1,040 439 89 418 72.9
Sulfathiazole 6 7.2 7.2 4 4.9 4.6 6 3.6 0.8
Sulpiride 91 218 70 95 199 120 89 178 32.9
Tetracycline 17 3,030 1,390 53 239 80 37 87.3 10.8
Theophylline 83 4,840 2,850 96 380 76 99 315 26.5
Thiamphenicol 0 0 0.4 8.1 8.1
Tiamulin 11 2.3 1.5 9 2.9 0.9 16 0.5 0.05
Triclosan 26 740 442 28 514 209 3 137 130
Trimethoprim 89 1,580 551 95 500 313 91 427 57.7
Tylosin 3 8.9 8.9 7 3.9 2.3 9 14.5 2.1
2 quinoxalinecarboxylicacid 3 14 14 51 23 14 35 22.6 5.6
STP Influent (n = 35) STP Effluent (n = 51) River water (n = 232)
Table S3.  Frequency of detection (freq.) and the maximum (Max.) and averaged concentration (Ave.) in STP influent and effluent and
                 river water samples.
Abbreviations: pharmaceuticals and personal care products (PPCPs), sewage treatment plant (STP), and N,N-Diethyl-m- toluamide
(DEET)
  
Table S4.  Removal of Target PPCPs at AS and TF STPs in Summer and Winter
Ave. SD Ave. SD Ave. SD Ave. SD
(%) (%) (%) (%) (%) (%) (%) (%)
Acetaminophen 2 100 0.04 1 100 7 99 1 2 99 0.4
Antipyrine 0 0 0 0
Atenolol 10 87 10 2 58 5 14 83 3 2 70 4
Azithromycin 5 39 18 2 21 31 5 53 30 2 15 6
Bezafibrate 12 84 12 2 32 3 14 56 14 2 -28 80
Caffeine 7 100 0.05 2 100 0.2 14 95 2 2 91 4
Carbamazepine 8 -15 35 2 -2 43 10 -7 25 2 10 2
Chloramphenicol 0 0 0 0
Chlortetracycline 0 0 0 0
Ciprofloxacin 1 86 0 5 23 45 0
Clarithromycin 7 87 8 2 50 7 8 37 29 2 30 21
Clenbuterol 0 0 0 0
Clofibric acid 0 0 0 0
Crotamiton 12 -29 32 2 -2 2 13 -8 49 2 13 21
Cyclophosphamide 4 -9 87 2 29 11 1 -241 0
DEET 11 80 17 2 7 24 13 27 111 2 16 30
Diclofec 5 19 23 2 -25 38 10 18 15 2 -12 22
Diltiazem 9 60 9 1 19 11 49 8 1 22
Dipyridamole 9 95 5 2 96 0.1 10 73 11 2 55 9
Disopyramide 10 -15 51 0 0 1 -20
Enrofloxacin 0 0 0 0
Ethenzamide 1 54 0 0 0
Fenoprofen 0 0 0 0
Furosemide 3 50 37 2 28 5 7 35 25 2 -4 26
Griseofulvin 2 16 26 0 0 0
Ibuprofen 1 100 0 0 0
Ifenprodil 0 0 0 0
Indometacin 1 5 2 25 17 8 -15 42 1 27
Isopropylantipyrine 0 2 -890 1,066 1 27 0
Ketoprofen 5 84 10 2 36 8 6 69 26 2 47 8
Levofloxacin 2 67 1 1 71 2 -22 33 0
Lincomycin 4 -39 179 0 2 38 5 0
Mefemic acid 10 26 23 2 7 31 14 31 26 2 -5 20
Metoprolol 11 26 15 2 28 24 14 33 33 2 47 6
Nalidixic acid 0 0 0 0
Naproxen 8 98 1 2 93 3 13 77 8 2 71 4
Norfloxacin 0 0 0 0
Oxytetracycline 3 94 4 0 1 92 0
Pirenzepine 2 37 7 1 -183 0 0
Primidone 6 -18 39 2 -20 16 10 -20 38 2 -11 2
Propranolol 11 -10 56 0 9 13 28 2 9 26
Roxithromycin 5 17 48 1 16 1 -289 0
Salbutamol 4 9 9 1 3 5 35 14 2 19 15
Sulfadimethoxine 0 0 1 13 0
Sulfadimidine 0 0 0 0
Sulfamerazine 3 84 8 2 -26 58 4 7 28 1 -1,150
Sulfamethoxazole 10 42 23 2 32 19 13 20 40 2 -15 41
Sulfamonomethoxine 0 0 0 0
Sulfapyridine 6 45 16 2 30 13 9 27 13 2 6 3
Sulfathiazole 0 0 0 0
Sulpiride 12 -21 55 2 -44 11 11 -58 74 2 -20 113
Tetracycline 3 93 7 0 1 84 0
Theophylline 7 99 0.4 2 99 0.1 14 93 2 2 83 3
Thiamphenicol 0 0 0 0
Tiamulin 0 0 2 2 36 0
Triclocarban 0 1 34 0 0
Triclosan 2 59 25 1 48 1 73 1 9
Trimethoprim 9 50 14 2 37 18 14 43 27 2 51 4
Tylosin 0 0 1 85 0
2-quinoxalinecarboxylicacid 0 0 1 -32 0





AS STPs (3 STPs) TF STP (2 STPs)
Winter
(data set = 2)
Winter
(data set = 2)
Summer
(data set = 12)
Summer








Figure S1.  Relative location of sampling sites, STP, and gauging stations used for the calculation of 
flow rate at river water sampling points (approximate distances). 
 
 
Figure S2.  Relationship between CFF/CBZ and total PPCPs detected in influent 
and effluent samples. 
Abbreviation: pharmaceuticals and personal care products (PPCPs), caffeine (CFF) and 
carbamazepine (CBZ)  
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 Figure S3.  Wastewater content estimated by crotamiton (CTT) in the northern tributaries (a), 
the main stem of the Thames, (b) and the southern tributaries, (c). 
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